Steven Paul
2021
In 2021, Steven Paul earned a total compensation of $13.1M as Chief Executive Officer, President and Chairman at Karuna Therapeutics, a 48% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $549,863 |
|---|---|
| Option Awards | $11,933,397 |
| Salary | $645,000 |
| Other | $8,700 |
| Total | $13,136,960 |
Paul received $11.9M in option awards, accounting for 91% of the total pay in 2021.
Paul also received $549.9K in non-equity incentive plan, $645K in salary and $8.7K in other compensation.
Rankings
In 2021, Steven Paul's compensation ranked 674th out of 12,415 executives tracked by ExecPay. In other words, Paul earned more than 94.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 674 out of 12,415 | 95th |
Division Manufacturing | 223 out of 5,505 | 96th |
Major group Chemicals And Allied Products | 71 out of 2,375 | 97th |
Industry group Drugs | 61 out of 2,096 | 97th |
Industry Pharmaceutical Preparations | 37 out of 1,546 | 98th |
Source: SEC filing on April 27, 2022.
Paul's colleagues
We found four more compensation records of executives who worked with Steven Paul at Karuna Therapeutics in 2021.